CEBPA and Alzheimer disease: After internalization by the adipose tissue, the exosomal miR-92a-3p inhibited the adipogenesis of AD-MSCs by reducing the expression of CCAAT/enhancer binding protein-alpha (C/EBPα) at the post-transcriptional level, and transfection of miR-92a-3p inhibitor blocked the anti-adipogenic effect of CML-derived exosomes [83].